BioLife Solutions, Inc. (BLFS) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 67.87M USD | Gross Profit |
| Revenue | (m) | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $67.87M | (m) | (m) | (m) |
| 2026-03-31 | $64.81M | (m) | (m) | (m) |
| 2025-12-31 | $62.12M | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) |
| 2024-12-31 | $50.10M | (m) | (m) | (m) |
| 2023-12-31 | $41.32M | (m) | (m) | (m) |
| 2019-09-30 | $17.13M | (m) | $7.40M | (m) |
| 2019-06-30 | $16.30M | (m) | $6.92M | (m) |
| 2019-03-31 | $15.20M | (m) | $6.50M | (m) |
| 2018-12-31 | $13.53M | (m) | $6.22M | (m) |
| 2018-09-30 | $11.62M | (m) | $5.80M | (m) |
| 2018-06-30 | $9.80M | (m) | $5.29M | (m) |
| 2018-03-31 | $7.76M | (m) | $4.71M | (m) |
| 2017-12-31 | $6.75M | (m) | $4.28M | (m) |
| 2017-09-30 | $6.27M | (m) | $3.86M | (m) |
| 2017-06-30 | $5.62M | (m) | $3.69M | (m) |
| 2017-03-31 | $5.14M | (m) | $3.61M | (m) |
| 2016-12-31 | $4.78M | (m) | $3.45M | (m) |
| 2016-09-30 | $4.55M | (m) | $3.24M | (m) |
| 2016-06-30 | $4.31M | (m) | $2.98M | (m) |
| 2016-03-31 | $4.01M | (m) | $2.79M | (m) |
| 2015-12-31 | $3.81M | (m) | $2.63M | (m) |
| 2015-09-30 | $3.67M | (m) | $2.63M | (m) |
| 2015-06-30 | $3.29M | (m) | $2.62M | (m) |
| 2015-03-31 | $3.01M | (m) | $2.61M | (m) |
| 2014-12-31 | $3.04M | $6.19M | $3.16M | 49.03% |
| 2014-09-30 | $2.96M | $6.81M | $3.85M | 43.43% |
| 2014-06-30 | $3.26M | $7.74M | $4.48M | 42.11% |
| 2014-03-31 | $3.54M | $8.85M | $5.31M | 39.99% |
| 2013-12-31 | $3.76M | $8.95M | $5.19M | 42.05% |
| 2013-09-30 | $3.59M | $8.71M | $5.11M | 41.27% |
| 2013-06-30 | $3.30M | $8.22M | $4.92M | 40.16% |
| 2013-03-31 | $2.93M | $6.99M | $4.06M | 41.91% |
| 2012-12-31 | $2.29M | $5.66M | $3.37M | 40.48% |
| 2012-09-30 | $2.00M | $4.42M | $2.43M | 45.16% |
| 2012-06-30 | $1.77M | $3.46M | $1.69M | 51.25% |
| 2012-03-31 | $1.65M | $2.98M | $1.33M | 55.32% |
| 2011-12-31 | $1.40M | $2.76M | $1.36M | 50.86% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $856.39K | $2.08M | $1.23M | 41.14% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |